Avidity Biosciences, Inc. (RNA)
USD 24.08
(-5.49%)
USD 24.08
(-5.49%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -181.4 Million USD | -4.82% |
| 2022 | 7.83 Million USD | -9.78% |
| 2021 | 8.68 Million USD | 128.19% |
| 2020 | -30.81 Million USD | -152.17% |
| 2019 | -12.22 Million USD | -51.67% |
| 2018 | -8.05 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 2.9 Million USD | 83.9% |
| 2024 Q2 | 1.35 Million USD | -53.2% |
| 2023 Q4 | 1.57 Million USD | 3.95% |
| 2023 Q1 | 1.15 Million USD | -51.68% |
| 2023 FY | 7.45 Million USD | -4.82% |
| 2023 Q2 | 1.05 Million USD | -8.58% |
| 2023 Q3 | 1.51 Million USD | 43.89% |
| 2022 Q3 | 2.08 Million USD | 105.54% |
| 2022 Q2 | -37.61 Million USD | -2639.57% |
| 2022 FY | 7.83 Million USD | -9.78% |
| 2022 Q1 | 1.48 Million USD | -9.91% |
| 2022 Q4 | 2.38 Million USD | 14.7% |
| 2021 Q1 | -17.97 Million USD | -56.6% |
| 2021 Q4 | 1.64 Million USD | 107.25% |
| 2021 Q3 | -22.66 Million USD | -12.78% |
| 2021 Q2 | -20.09 Million USD | -11.83% |
| 2021 FY | 8.68 Million USD | 128.19% |
| 2020 FY | -30.81 Million USD | -152.17% |
| 2020 Q4 | -11.47 Million USD | -48.88% |
| 2020 Q3 | -7.7 Million USD | -3.57% |
| 2020 Q2 | -7.44 Million USD | -77.81% |
| 2020 Q1 | -4.18 Million USD | 0.33% |
| 2019 Q4 | -4.2 Million USD | 5.6% |
| 2019 FY | -12.22 Million USD | -51.67% |
| 2019 Q1 | -1.26 Million USD | 0.0% |
| 2019 Q2 | -2.3 Million USD | -82.96% |
| 2019 Q3 | -4.44 Million USD | -92.68% |
| 2018 FY | -8.05 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 120.47 Million USD | 250.579% |
| Jaguar Health, Inc. | 7.72 Million USD | 2448.628% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -27220.482% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -3628060.0% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 111.951% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 251.485% |
| ContextLogic Inc. | 59 Million USD | 407.471% |
| MiMedx Group, Inc. | 266.84 Million USD | 167.983% |
| MEI Pharma, Inc. | 49.32 Million USD | 467.766% |
| AlloVir, Inc. | -398 Thousand USD | -45479.899% |
| Novavax, Inc. | 639.93 Million USD | 128.348% |
| Aptorum Group Limited | -1.11 Million USD | -16174.33% |
| Ardelyx, Inc. | 106.66 Million USD | 270.079% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 175.356% |
| Psyence Biomedical Ltd. | -240.00 USD | -75586566.667% |
| Vaxcyte, Inc. | -75 Million USD | -141.877% |
| Precigen, Inc. | 106 Thousand USD | 171239.623% |
| Pharming Group N.V. | 220.1 Million USD | 182.419% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 35324.854% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 18078.989% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 265.259% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -35005.835% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Bicycle Therapeutics plc | -129.52 Million USD | -40.062% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -300.238% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -725.069% |
| Acelyrin, Inc. | -115 Thousand USD | -157646.087% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -31670.228% |
| Senti Biosciences, Inc. | -2.68 Million USD | -6661.387% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 4578.104% |
| AbCellera Biologics Inc. | 38.02 Million USD | 577.076% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -3680.909% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 151273.333% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 722.775% |
| Chimerix, Inc. | 324 Thousand USD | 56090.123% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 36674.194% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -221129.268% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -482.039% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -36771.545% |
| Elevation Oncology, Inc. | -39 Thousand USD | -465048.718% |
| Alkermes plc | 1.37 Billion USD | 113.196% |
| Fortress Biotech, Inc. | 57.85 Million USD | 413.567% |
| Fortress Biotech, Inc. | 57.85 Million USD | 413.567% |
| Agenus Inc. | 139.61 Million USD | 229.934% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 1194.336% |
| Dyadic International, Inc. | 922.95 Thousand USD | 19755.087% |
| ImmuCell Corporation | 4.39 Million USD | 4226.394% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 961.346% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | -70.941% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -103654.797% |
| Immix Biopharma, Inc. | -5468.00 USD | -3317529.846% |
| Incyte Corporation | 3.44 Billion USD | 105.272% |
| IO Biotech, Inc. | -756 Thousand USD | -23895.767% |
| Janux Therapeutics, Inc. | -46.83 Million USD | -287.301% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -1258.063% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -410436.797% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | -84.701% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -329732.727% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 22719.451% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -34322.77% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 717.307% |
| NextCure, Inc. | -3.68 Million USD | -4824.213% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 1052.623% |
| Onconetix, Inc. | -1.12 Million USD | -15994.183% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -526.236% |
| Opthea Limited | 21.72 Thousand USD | 835311.786% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -316349.778% |
| PureTech Health plc | -1.6 Million USD | -11216.781% |
| Pyxis Oncology, Inc. | -2 Million USD | -8970.4% |
| Seer, Inc. | 7.02 Million USD | 2681.585% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -1804775.137% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 2404.764% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -4501.872% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 42884.906% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 274.265% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 234.109% |
| C4 Therapeutics, Inc. | -96.95 Million USD | -87.115% |
| ChromaDex Corporation | 50.78 Million USD | 457.243% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -78093.103% |
| Caribou Biosciences, Inc. | -77.59 Million USD | -133.779% |
| CRISPR Therapeutics AG | 240.95 Million USD | 175.287% |
| Precision BioSciences, Inc. | 40.47 Million USD | 548.231% |
| Fate Therapeutics, Inc. | -98.16 Million USD | -84.803% |
| Innoviva, Inc. | 261.06 Million USD | 169.488% |
| Summit Therapeutics Inc. | -2.05 Million USD | -8749.171% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 4243.627% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 941.996% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -152998.548% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -126492.278% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 29887.849% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 157.834% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 7147.708% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -357424.635% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -2455.762% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -38127.776% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -1744207.692% |
| Soligenix, Inc. | 97.31 Thousand USD | 186520.857% |
| Century Therapeutics, Inc. | -10.8 Million USD | -1578.305% |
| Kura Oncology, Inc. | -849 Thousand USD | -21267.256% |
| TScan Therapeutics, Inc. | -67.1 Million USD | -170.339% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -123306.803% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 283.168% |
| Autolus Therapeutics plc | -4.86 Million USD | -3627.306% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 538.332% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -107880.952% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 291.514% |
| GRI Bio, Inc. | 10.84 Million USD | 1773.351% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 7242.087% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -1988.27% |
| IGM Biosciences, Inc. | -211.66 Million USD | 14.293% |
| INmune Bio, Inc. | 155 Thousand USD | 117137.419% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 392.882% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -11943.357% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -27875.462% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -619589.827% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 45226.368% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -8988.577% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -57857.827% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 292.045% |
| Verastem, Inc. | -62 Thousand USD | -292493.548% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 7550.021% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -69404.981% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 6092.996% |
| Histogen Inc. | 3.76 Million USD | 4913.16% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 31584.66% |
| Surrozen, Inc. | -27.23 Million USD | -566.206% |
| Organovo Holdings, Inc. | -5.38 Million USD | -3266.265% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -14956.105% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | -607.326% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 1004.688% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -9161920.202% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 3090.362% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -270129.849% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 217.195% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 124522.497% |
| Apollomics, Inc. | 127 Thousand USD | 142940.945% |
| Amarin Corporation plc | 165.54 Million USD | 209.585% |
| Mesoblast Limited | -9.81 Million USD | -1748.273% |
| Turnstone Biologics Corp. | 16.5 Million USD | 1199.043% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | -64.186% |
| Synaptogenix, Inc. | -6347.00 USD | -2858069.214% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -355601.961% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 212.421% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 110.321% |
| Better Therapeutics, Inc. | -2.72 Million USD | -6547.417% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | -61.739% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 153.658% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -1590082.328% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -2797.891% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -16272.563% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 2578.928% |
| Insmed Incorporated | 239.63 Million USD | 175.702% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| MediWound Ltd. | 3.57 Million USD | 5170.095% |
| OmniAb, Inc. | 14.66 Million USD | 1336.845% |
| Alector, Inc. | -95.05 Million USD | -90.849% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 244.409% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -317.385% |
| Zai Lab Limited | 170.9 Million USD | 206.147% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 321.562% |
| Aura Biosciences, Inc. | -1.29 Million USD | -13908.34% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 139644.615% |
| Immunic, Inc. | -111 Thousand USD | -163330.631% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 1244.241% |
| Veracyte, Inc. | 248.14 Million USD | 173.105% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 97.404% |
| FibroGen, Inc. | 128.9 Million USD | 240.731% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -32164439.007% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -1454.897% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 105.338% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 46734.447% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 151.051% |
| TG Therapeutics, Inc. | 219.1 Million USD | 182.794% |
| Galecto, Inc. | -830 Thousand USD | -21756.386% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -12998.051% |
| Fortrea Holdings Inc. | 424 Million USD | 142.785% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | -110.531% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -31894.356% |
| XBiotech Inc. | -1.74 Million USD | -10301.835% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -16272.563% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | -290.368% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | -140.167% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 347.14% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 1179.617% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 146.63% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | -265.396% |
| Vaxxinity, Inc. | -2.23 Million USD | -8020.322% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 155.519% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -1502.0% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 841.925% |
| NexImmune, Inc. | -1.02 Million USD | -17598.825% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 3359507.407% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -2453.008% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 101.605% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -271359.141% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -5008.645% |
| Ainos, Inc. | -253.73 Thousand USD | -71395.627% |
| Pluri Inc. | 322 Thousand USD | 56437.888% |
| Prothena Corporation plc | -129.2 Million USD | -40.408% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 459.766% |
| Celularity Inc. | 6.75 Million USD | 2785.537% |
| Rallybio Corporation | -150 Thousand USD | -120838.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | -456.347% |
| MeiraGTx Holdings plc | 287 Thousand USD | 63308.362% |
| Omeros Corporation | -69.77 Million USD | -159.975% |
| Humacyte, Inc. | -76.55 Million USD | -136.98% |
| Immunocore Holdings plc | 248.39 Million USD | 173.033% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -1095.913% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 390.802% |
| Blueprint Medicines Corporation | 236.58 Million USD | 176.678% |
| CalciMedica, Inc. | -58 Thousand USD | -312672.414% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -12621.459% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 724.361% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -6278.622% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -487.747% |
| Pulmatrix, Inc. | -8.22 Million USD | -2106.91% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -15404.957% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -45365.664% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 54.511% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 6635.847% |
| Cytokinetics, Incorporated | -322.59 Million USD | 43.766% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 21142.448% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -53098.827% |
| Vor Biopharma Inc. | -3.49 Million USD | -5094.96% |
| Roivant Sciences Ltd. | 109.23 Million USD | 266.071% |
| Evogene Ltd. | 1.39 Million USD | 13066.976% |
| ProKidney Corp. | -3.16 Million USD | -5624.456% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -313.117% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 2745.588% |
| CorMedix Inc. | -205.56 Thousand USD | -88149.774% |
| BioLineRx Ltd. | 1.1 Million USD | 16472.563% |
| Tango Therapeutics, Inc. | -78.67 Million USD | -130.591% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -549621.212% |
| Atai Life Sciences N.V. | -5000.00 USD | -3628060.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -148767.133% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -188866.667% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -12960.331% |
| Sagimet Biosciences Inc. | 2 Million USD | 9170.4% |
| MediciNova, Inc. | 979.7 Thousand USD | 18616.594% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | -115.145% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -191754.476% |
| GeoVax Labs, Inc. | -20.72 Million USD | -775.489% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 174.185% |
| Biomea Fusion, Inc. | -4.2 Million USD | -4218.21% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 120.796% |
| Mereo BioPharma Group plc | 7.42 Million USD | 2542.876% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -58418.71% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -1511633.333% |
| Absci Corporation | -41.84 Million USD | -333.482% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -3628060.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | -137.529% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -7271.312% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 184.875% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -19178.215% |
| Allakos Inc. | -6.14 Million USD | -2854.047% |
| Imunon, Inc. | -720 Thousand USD | -25095.381% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | -162.925% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 138.119% |
| BioAtla, Inc. | -103.73 Million USD | -74.883% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -1590082.328% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -101814.607% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 25.291% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -58230.547% |
| XOMA Corporation | 3.86 Million USD | 4798.472% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | -158.84% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 1326.227% |
| aTyr Pharma, Inc. | -2.38 Million USD | -7496.65% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 1555.923% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -625444.828% |
| Viridian Therapeutics, Inc. | -1 Million USD | -17896.825% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 1395446253.846% |
| Akari Therapeutics, Plc | -4000.00 USD | -4535100.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 128.483% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 93269.259% |
| UroGen Pharma Ltd. | 73.35 Million USD | 347.312% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -579.583% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 1562615.073% |
| Orgenesis Inc. | -5.72 Million USD | -3068.699% |
| Entera Bio Ltd. | -56 Thousand USD | -323842.857% |
| GH Research PLC | -315 Thousand USD | -57489.841% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -95883.069% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -34453.905% |
| Xencor, Inc. | -85.26 Million USD | -112.77% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -81993.612% |
| Replimune Group, Inc. | -2.65 Million USD | -6732.693% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -18018.406% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 202.004% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 93269.259% |
| Portage Biotech Inc. | -54 Thousand USD | -335840.741% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -191754.476% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -48018.833% |
| OncoCyte Corporation | 413 Thousand USD | 44024.455% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -4035673.081% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -81715215.315% |
| Purple Biotech Ltd. | -196 Thousand USD | -92455.102% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 2122.837% |
| scPharmaceuticals Inc. | 9.78 Million USD | 1954.508% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -1636.8% |
| HilleVax, Inc. | -2.15 Million USD | -8314.1% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -186918.557% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -1208964.25% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -27056.886% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -788630.435% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -2416688.345% |
| Savara Inc. | -44.26 Million USD | -309.85% |
| Curis, Inc. | 9.81 Million USD | 1949.027% |
| Daré Bioscience, Inc. | 2.76 Million USD | 6650.156% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -145272.953% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -10392.076% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -79464.912% |
| BeiGene, Ltd. | 2.07 Billion USD | 108.726% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -6388.358% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 54.61% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 420.011% |
| Erasca, Inc. | -3.73 Million USD | -4760.879% |
| bluebird bio, Inc. | -4.03 Million USD | -4401.439% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -642780.431% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 109.526% |
| DBV Technologies S.A. | 15.72 Million USD | 1253.408% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -642780.431% |
| Moderna, Inc. | 2.15 Billion USD | 108.418% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -19726.011% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 2365.901% |
| Molecular Templates, Inc. | 50.39 Million USD | 459.972% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -33744.776% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 235.594% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -2815.59% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -361.093% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | -63.242% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -4955.964% |
| MacroGenics, Inc. | 50.52 Million USD | 459.032% |
| RenovoRx, Inc. | - USD | Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | -2874.877% |
| Prime Medicine, Inc. | -147.9 Million USD | -22.652% |
| Aditxt, Inc. | -111.66 Thousand USD | -162364.625% |
| Adagene Inc. | 18.11 Million USD | 1101.618% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 37273.77% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 229.39% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 214.934% |
| SciSparc Ltd. | 2.19 Million USD | 8360.838% |
| Vericel Corporation | 135.57 Million USD | 233.805% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -724112.543% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -585427.08% |
| Generation Bio Co. | -73.91 Million USD | -145.441% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -41412.128% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 432.134% |
| Invivyd, Inc. | -2.02 Million USD | -8845.168% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 39.7% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -175278.488% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 288.245% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 284.568% |
| ADMA Biologics, Inc. | 88.21 Million USD | 305.636% |
| Clene Inc. | 533 Thousand USD | 34135.272% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 852.444% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -18855.904% |
| GeoVax Labs, Inc. | -20.72 Million USD | -775.489% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 9225.151% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -93257.212% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 464.237% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -2457.924% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -21599.522% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 317.476% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 248223.427% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 441.236% |
| Verve Therapeutics, Inc. | -173.18 Million USD | -4.746% |
| Trevena, Inc. | 1.45 Million USD | 12567.904% |
| Surrozen, Inc. | -27.23 Million USD | -566.206% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -51290.368% |
| Cingulate Inc. | -582.91 Thousand USD | -31020.672% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -585087.097% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -820.9% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -2396306.869% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -20491.146% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 126.65% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -18261.134% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -321876.501% |
| Kronos Bio, Inc. | 1.37 Million USD | 13322.157% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | -238.032% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -62026.027% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -37049.867% |
| ImmunityBio, Inc. | -17.89 Million USD | -914.019% |
| Korro Bio, Inc. | -3.63 Million USD | -4897.466% |
| Kineta, Inc. | 5.43 Million USD | 3439.002% |
| BioVie Inc. | -229.37 Thousand USD | -78987.267% |
| Codexis, Inc. | 57.33 Million USD | 416.406% |
| Celularity Inc. | 6.75 Million USD | 2785.537% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 4620.508% |
| Celcuity Inc. | -142.77 Thousand USD | -126961.329% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 358684.701% |
| Cibus, Inc. | 1.42 Million USD | 12857.243% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -48404.813% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | -691.518% |
| IN8bio, Inc. | -2.5 Million USD | -7153.419% |
| Kodiak Sciences Inc. | -25.94 Million USD | -599.148% |
| Annexon, Inc. | -3.26 Million USD | -5452.74% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -8775.147% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -334.646% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 28445.0% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 123.302% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 204.887% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -9447.789% |
| Arcellx, Inc. | 108.27 Million USD | 267.538% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -460.437% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 329.039% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -757.64% |
| Moolec Science SA | -143.3 Thousand USD | -126488.744% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -328.678% |
| Geron Corporation | -123.5 Million USD | -46.886% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 5618.953% |
| Royalty Pharma plc | 1.79 Billion USD | 110.113% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | -158.822% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -5022269.878% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 78498.901% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | -62.823% |
| Humacyte, Inc. | -76.55 Million USD | -136.98% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -19012.196% |
| 89bio, Inc. | -273 Thousand USD | -66349.817% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -14331.822% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -21292.453% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -147386.179% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 16311.618% |
| Notable Labs, Ltd. | 113 Thousand USD | 160638.053% |
| Liquidia Corporation | 14.6 Million USD | 1342.521% |
| Mustang Bio, Inc. | -2.22 Million USD | -8053.169% |
| Immunovant, Inc. | -231 Thousand USD | -78431.602% |
| Quantum-Si incorporated | 488 Thousand USD | 37273.77% |
| Arbutus Biopharma Corporation | -55.55 Million USD | -226.514% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -604593.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 9842.642% |
| Acasti Pharma Inc. | -11 Thousand USD | -1649063.636% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -88557.345% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -27875.462% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | -8.296% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 16089.0% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -47513.648% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -9164.964% |
| PepGen Inc. | -1.18 Million USD | -15221.622% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -142740.945% |
| United Therapeutics Corporation | 2.07 Billion USD | 108.764% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -692.278% |
| Solid Biosciences Inc. | -76.56 Million USD | -136.94% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -219567.486% |
| Immuneering Corporation | -764.13 Thousand USD | -23640.214% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 273865.544% |
| Belite Bio, Inc | -399 Thousand USD | -45365.664% |
| XOMA Corporation | 3.86 Million USD | 4798.472% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -805.41% |
| Bionomics Limited | -434.44 Thousand USD | -41655.879% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -16790.875% |
| uniQure N.V. | 2.21 Million USD | 8289.977% |
| Cassava Sciences, Inc. | -89.42 Million USD | -102.865% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | -97.035% |
| Forte Biosciences, Inc. | -9000.00 USD | -2015544.444% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -21625.509% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -41412.128% |
| Altimmune, Inc. | -65.37 Million USD | -177.497% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 150.109% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -16790.875% |
| Compugen Ltd. | 31.45 Million USD | 676.722% |
| Peak Bio, Inc. | 367.76 Thousand USD | 49426.615% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 839.958% |
| Benitec Biopharma Inc. | 108 Thousand USD | 168070.37% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -232474.359% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -14979.634% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -9856.531% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -152343.697% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -14979.634% |
| Instil Bio, Inc. | -4.75 Million USD | -3714.298% |
| argenx SE | 1.1 Billion USD | 116.365% |
| Immunome, Inc. | -8.9 Million USD | -1936.69% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -9498.307% |
| Verona Pharma plc | -679.62 Thousand USD | -26592.406% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -103561.714% |
| Shattuck Labs, Inc. | -2.38 Million USD | -7506.205% |
| CervoMed Inc. | -1.29 Million USD | -13923.208% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -7436.685% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -3697.53% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 7441.481% |
| Moolec Science SA | -143.3 Thousand USD | -126488.744% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -44359.476% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -6690.421% |
| AnaptysBio, Inc. | 14.78 Million USD | 1327.305% |
| Design Therapeutics, Inc. | -537 Thousand USD | -33681.75% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -42384.309% |
| NeurAxis, Inc. | 2.15 Million USD | 8511.354% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 8553.308% |
| Lumos Pharma, Inc. | 2 Million USD | 9138.764% |
| Achilles Therapeutics plc | -4.73 Million USD | -3734.237% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -103561.714% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -171565.957% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 673.011% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 21142.448% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -17478.295% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | -298.279% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 421979.07% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -21969.1% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -1378589.77% |
| Palisade Bio, Inc. | 246 Thousand USD | 73843.089% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -549621.212% |
| Beam Therapeutics Inc. | -59.67 Million USD | -204.009% |
| Neurogene Inc. | -3.26 Million USD | -5461.251% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 230.196% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -4813.543% |
| Sesen Bio, Inc. | 40 Million USD | 553.52% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -60980.135% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -4404.751% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -1796.383% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 1388.409% |
| Athira Pharma, Inc. | -969 Thousand USD | -18621.156% |
| Vaccinex, Inc. | -16 Million USD | -1033.517% |
| HCW Biologics Inc. | -574.82 Thousand USD | -31458.877% |
| XOMA Corporation | 3.86 Million USD | 4798.472% |
| Nektar Therapeutics | 53.47 Million USD | 439.22% |
| Arvinas, Inc. | 71.8 Million USD | 352.657% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | -117.357% |
| Omega Therapeutics, Inc. | -62.77 Million USD | -188.981% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -56237.888% |
| Rezolute, Inc. | -36 Thousand USD | -503811.111% |
| Clene Inc. | 533 Thousand USD | 34135.272% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -14128248.91% |
| BeyondSpring Inc. | 1.75 Million USD | 10460.251% |
| Synlogic, Inc. | -1.92 Million USD | -9328.69% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -490191.892% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -2764.94% |
| Peak Bio, Inc. | 367.76 Thousand USD | 49426.615% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -856.642% |
| Krystal Biotech, Inc. | 47.6 Million USD | 481.069% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 228.575% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 3710.109% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -6906.283% |
| MannKind Corporation | 136.19 Million USD | 233.201% |
| Ikena Oncology, Inc. | -50.49 Million USD | -259.281% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 266.714% |
| Gossamer Bio, Inc. | -4.38 Million USD | -4037.013% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -71887.302% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -3628060.0% |
| Legend Biotech Corporation | 140.92 Million USD | 228.723% |
| Mural Oncology plc | -2.56 Million USD | -6966.926% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -32823.412% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -181308.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 974.087% |
| REGENXBIO Inc. | 53.02 Million USD | 442.092% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -3286.403% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -94199.155% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -10373.903% |
| Vaxart, Inc. | -60.76 Million USD | -198.55% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -68934.173% |
| Cellectis S.A. | 18 Thousand USD | 1007922.222% |
| Longeveron Inc. | 221 Thousand USD | 82185.068% |
| Repare Therapeutics Inc. | -80.07 Million USD | -126.562% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 116.597% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -13919.165% |
| Revolution Medicines, Inc. | -399.66 Million USD | 54.61% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -518208.571% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 370320.408% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 102.108% |
| Denali Therapeutics Inc. | -93.34 Million USD | -94.341% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -724112.543% |
| Veru Inc. | 7.56 Million USD | 2497.697% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -120037.748% |
| Cingulate Inc. | -582.91 Thousand USD | -31020.672% |
| Passage Bio, Inc. | -3.72 Million USD | -4775.249% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -1506110.561% |
| Exicure, Inc. | -1.42 Million USD | -12648.278% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -47265.013% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 6811.358% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -35284.6% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 366.283% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -121156.358% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | -206.401% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 46495.908% |
| OmniAb, Inc. | 14.66 Million USD | 1336.845% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 1007.358% |
| Lipocine Inc. | -2.85 Million USD | -6263.367% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -9743.082% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -3079.807% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -11943.357% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 340.862% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -278989.231% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 315.204% |
| Ocugen, Inc. | -33.53 Million USD | -440.919% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -5637.128% |
| Q32 Bio Inc. | 578 Thousand USD | 31485.467% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -68355.849% |
| Alumis Inc. Common Stock | -1.28 Million USD | -14028.349% |
| Equillium, Inc. | 35.95 Million USD | 604.5% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -10527.299% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 36332.396% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -4388095.452% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -69941.699% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 43015.271% |
| Dominari Holdings Inc. | 2.03 Million USD | 8996.91% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -98775.572% |
| vTv Therapeutics Inc. | -13.59 Million USD | -1234.373% |
| Bio-Techne Corporation | 773.07 Million USD | 123.466% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 1147.451% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 139.369% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -15418.221% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -656.497% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 1650.893% |
| Nkarta, Inc. | -5.86 Million USD | -2990.952% |
| BioCardia, Inc. | -7.24 Million USD | -2402.524% |
| Iterum Therapeutics plc | -1.75 Million USD | -10266.171% |